<SEC-DOCUMENT>0001576885-25-000096-index.html : 20251110
<SEC-HEADER>0001576885-25-000096.hdr.sgml : 20251110
<ACCEPTANCE-DATETIME>20251110164617
ACCESSION NUMBER:		0001576885-25-000096
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20251106
FILED AS OF DATE:		20251110
DATE AS OF CHANGE:		20251110

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Golumbeski George
		CENTRAL INDEX KEY:			0001586660
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40551
		FILM NUMBER:		251467051

	MAIL ADDRESS:	
		STREET 1:		C/O CELGENE CORP.
		STREET 2:		86 MORRIS AVENUE
		CITY:			SUMMIT
		STATE:			NJ
		ZIP:			07901

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acumen Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001576885
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				364108129
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1210-1220 WASHINGTON STREET
		STREET 2:		SUITE 210
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02465
		BUSINESS PHONE:		617-344-4190

	MAIL ADDRESS:	
		STREET 1:		1210-1220 WASHINGTON STREET
		STREET 2:		SUITE 210
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02465
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>wk-form3_1762811173.xml
<DESCRIPTION>FORM 3
<TEXT>
Document 1 - file: wk-form3_1762811173.html

Document 1 - RAW XML: wk-form3_1762811173.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>2
<FILENAME>ex241acumen-section16lim.htm
<DESCRIPTION>EX-24.1
<TEXT>
Document 2 - file: ex241acumen-section16lim.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex241acumen-section16lim001.jpg
<TEXT>
Document 3 - file: ex241acumen-section16lim001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex241acumen-section16lim002.jpg
<TEXT>
Document 4 - file: ex241acumen-section16lim002.jpg

</DOCUMENT>
</SEC-DOCUMENT>